search for




 


General rules for manuscripts


 
  • 1. Contribution Requirement and Scope of Content There are no specific limits to contribution requirements, but the scope of content should be in accord with the "Aims & Scope" of the journal. The manuscript categories are listed as: editorial, original article, review article, case report, brief communication, commentary or opinion, and letters to the editor.
  • 2. Authorship Those who made a substantial intellectual contribution in writing the manuscript should be included as an author. The authorship requires substantial contributions to (a) the conception and design or analysis and interpretation of the data, (b) the drafting of the article or critical revision for important intellectual content, (c) final approval of the version to be published, and (d) agreement accountable for all aspects of the work in ensuring the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The other contributions including providing funding or simple technical support should be mentioned in the Acknowledgment section. The primary investigator is designated the first author of the study, unless contested by the other authors. The corresponding author is directly responsible for communication and revision of the submitted manuscript. The corresponding author must submit all authors' signatures in the Copyright Transfer Form. Any authorship changes after submission must be agreed by all of the authors and approved by the editorial board when they submit the revised manuscript.
  • 3. Originality and Duplicate Publication All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutes will be informed. There will also be penalties for the authors. If the author(s) wishes to obtain a duplicate or secondary publication for various other reasons, such as for readers of a different language, he/she should obtain approval from the editors-in-chief of both the first and second journal.
  • 4. Conflicts of Interest All authors are required to report potential conflicts of interest that could inappropriately influence the author's work. This includes any financial or other relationships with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict.
  • 5. Research and Publication Ethics All manuscripts should be written with strict adherence to the ethical guidelines recommended by the International Committee of Medical Journal Editors (http://www.icmje.org). Issues of ethical misconduct, plagiarism, and duplicate/redundant publication will be judged and dealt with according to the “Good Publication Practice Guidelines for Medical Journals” (http://kamje.or.kr/publishing_ethics.html). For all studies involving human subjects, the principles embodied in the Declaration of Helsinki (http://www.wma.net/en/20activities/10ethics/10helsinki/index.html) should be upheld, informed consent must be obtained from all participants, and must be approved by a recognized Institutional Review Board (IRB) or research ethics committee. Experiments involving animals should comply with the NIH guidelines for the use of laboratory animals (http://www.olaw.nih.gov) and/or be reviewed by an appropriate committee (Institutional Animal Care and Use Committee, IACUC) to ensure the ethical treatment of animals in research. The content of each article is responsible of the authors and not that of the Korean Surgical Ultrasound Society. For the policies on the research and publication ethics not stated in these instructions, International standards for editors and authors (http://publicationethics.org/international-standards-editors-and-authors) can be applied.
  • 6. Peer Review Process Submitted manuscripts will be reviewed by two peer reviewers selected from the Board’s database of expert reviewers. Following review, the Editorial Board will decide whether the manuscript will be 1) acceptance, 2) minor revision, 3) major revision, or 4) rejection. For manuscripts which are either accepted for publication following re¬vision or subject to major revision, the corresponding author must resubmit the revised manuscript online. The revised manuscript should have the changes highlighted by using the Track Changes tool in Microsoft Office Word. In addition, the corresponding author must reply to both reviewers’ comments point by point, and explain in de¬tail what changes were made in the manuscript. When considered necessary, the Editorial Board may make changes to the structure and phrases of the manuscript without compromising the integrity of the original paper. After completion of the peer review process, the Edito¬rial Board will determine acceptance for publication and notify the corresponding author by e-mail. Manuscripts which do not comply with the present guidelines will be notified for correction or withheld from publication. When a manuscript is not resubmitted within 2 months of notification, it will be considered that the authors have withdrawn the manuscript from submission. Manu¬scripts accepted for publication are generally published in order of submission, depending on the category of the manuscript and the date of acceptance for publication.
  • 7. Manuscript Submission Manuscripts should be submitted via our online manuscript submission system (www.jsu.or.kr/main.html). Submitted manuscripts are initially examined for format, and then appointed a submission number. The date of final review for the manuscript will be the date of acceptance for publication. For nonbiased peer review, authors’ names and institutional affiliations should not be mentioned in the text. If there is any inquiry concerning manuscript submission, contact the address below.
  • Editorial Office Hyun Jo Youn, Editor-in-Chief
    Department of Surgery, Jeonbuk National University Medical School
    20, Geonjiro, Deokjin-gu, Jeonju, Jeollabuk-do, 54907, Rep. of Korea
    Tel: +82-63-250-1570
    Fax: +82-63-271-6197
    E-mail: yhj0903@jbnu.ac.kr

    • 1) Copyright transfer All submitted manuscripts must be accompanied by the official Submission Application & Copyright Transfer Form of the Korean Surgical Ultrasound Society. The Form must contain the title of the manuscript, date of submission, names of all authors, authors’ affiliations, and written signatures. Note the corresponding author and provide his/her affiliation, e-mail, telephone and fax numbers, and mailing address. The Form must be sent to the Editor office by fax or postal service.
    • 2) Subscription fare and publication charges Hard copy of the JSU is distributed in free of charge to the members of the Korean Surgical Ultrasound Society and selected institutions. Any other institutions interested in subscription can request to the Korean Surgical Ultrasound Society. Once the Korean Surgical Ultrasound Society admits the subscription request, hard copy of the JSU will be delivered only with a shipping charge. Publication charges for the authors are free.
  • 8. Copyright and Creative Commons License The Korean Surgical Ultrasound Society is the owner of all copyright to papers published in the JSU, and has the right to publish, reproduce, distribute, and print the contents in other types of media. They are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/). Authors of accepted papers must complete the Copyright Transfer Agreement. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, illustrations, and tables.

Detailed rules for manuscripts


  • 1. Manuscript Preparation Manuscripts must be clearly and concisely written in Korean or English, and authors are urged to aim for clarity, brevity, and accuracy of information and language. The main document with manuscript text and tables should be prepared with Microsoft Word. The manuscript must be written in 12-point 맑은 고딕 font in a Korean manuscript and the Times New Roman font for English text and the sentences must be double-spaced, including tables and figure legends. Setup the MS Word document for 1-inch margins on letter or A4-sized paper. The text of the manuscript should begin with the title page followed by an abstract, a list of key words, the main body, references, and tables and/or figures. Indent new paragraphs and do not use the Enter key at the end of lines within a paragraph. Turn the hyphenation option off. Include hyphens only where they are essential to the meaning. All medical terminology follows the English-Korean, Korean-English Medical Terminology, 4th edition, 2001 (www.kamje.or.kr/term/). In Korean manuscripts, the original language, including English, can be used when there is no appropriate Korean equivalent in the case of a medical term, proper noun, toponym, personal name, drug name, and units of measurements. When the Korean equivalent is inexplicit, use the equivalent initially followed by the original language in parentheses. Thereafter, use the Korean equivalent only. When using an abbreviated word, it should be spelled out in full on first usage in the manuscript followed by the abbreviation in parentheses. Numbers should be written in Arabic numerals, but must be spelled out when placed in the beginning of a sentence. Measurements should be reported using the metric system, and hematologic and biochemical markers should be reported in International System (SI) of Units (http://physics.nist.gov/cuu/Units/index.html). All units must be preceded by one space except percentage (%), temperature (°C), and degree (°). At the first mention of a chemical substance, give the generic name only. When quoting specific chemical materials, software, equipment, and proprietary drugs, the name and address of the manufacturer must be given in parentheses. Footnotes to the text are not allowed and such material must be incorporated into the text as parentheticals.
  • 2. Form of Manuscripts: Original article The original articles should be structured in the following order: Abstract, Introduction, Methods, Results, Discussion, Conflicts of interest, Acknowledgments (when applicable), References, Tables, Figure legends, and Figures. Maximum page count (excepting tables and figures) is limited to 20 pages.
    • (1) Title Page The Title Page should contain the title of the manuscript, the authors’ names, academic degrees, and respective affiliations. The corresponding author must be identified, and his or her contact information (postal address, e-mail, telephone and fax numbers) should be listed.
    • (2) Title The title should clearly describe the objective of the study and contain less than 20 words. All the words in the title should be in capital letters except for prepositions, articles, and conjunctions. Provide a short running title containing less than 10 words. Title pages or notes related to the text should not be included in the submitted file before the approval for publication.
    • (3) Abstract A structured abstract with the headings of Purpose, Methods, Results, and Conclusion must succinctly describe the paper in 250 words or less. Use complete sentences and do not number the results.
    • (4) Key Words At the end of the Abstract, list up to 5 relevant Key Words which are in accordance to the Medical Subject Headings (MeSH) in the Index Medicus (http://www.nlm.nih.gov/mesh). In a Korean manuscript, the key words should be listed in both English and Korean. For example, Key Words: Ultrasound, Abdomen, Breast, Vascular and 중심 단어: 초음파, 복부, 유방, 혈관
    • (5) Main Body
      • 1) Introduction Clearly present the objective of the study and its relationship to earlier work in the field. A brief background to inform the readers of the relevance of the study may be necessary. However, avoid extensive review of the literature.
      • 2) Methods Describe the participants or research materials of the study, and explain in detail the inclusion and exclusion criteria for both the experimental and control groups. Describe the experimental methods in a logical and systematic manner so that they can be reproducible by another investigator. Experimental drugs should be stated in the generic name. When proprietary brands are used, include the brand name and the name of the manufacturer in parentheses after the first mention of the generic name. When using experimental devices or other products, state the brand name then follow with the name of the manufacturer, city (state), and country in parentheses, e.g., Flow Cytometer (Coulter Electronic Inc., New York, NY, USA). To ensure anonymity during the peer review process, the authors’ affiliations or institutional setting of the study should not be revealed. Statistical analysis and criteria for determining significance should be described in enough detail to allow the knowledgeable reader with access to the original data to verify the reported results.
      • 3) Results Summarize and describe logically the significant findings and trends observed in the results using text, figures and tables. Avoid extensive repetition of contents of the tables and figures in the text. In statistical expression, mean and standard deviation should be described as mean±SD, and mean and standard error as mean±SE. In general, p-values larger than 0.01 should be reported to two decimal places, those between 0.01 and 0.001 to three decimal places; p-values smaller than 0.001 should be reported as p<0.001.
      • 4) Discussion Interpret the results in respect to the objective of the study, and describe differences with previous studies and significant findings which lead to the deduction of the conclusion. Refrain from excessive review of historic studies, textbook facts, or irrelevant references. Accentuate newly obtained observations from the study, and include significant limitations of the study.
      • 5) Conclusion State the main conclusion related to the aims of the study and supported by the results.
      • 6) Conflicts of interest This includes any financial or other relationships with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict.
      • 7) Acknowledgments Persons who have made contributions to the study, but who are not eligible for authorship can be named in this section. Their contribution must be specified, such as data collection, financial support, statistical analysis, or experimentation. The corresponding author must inform the named contributor of the acknowledgment, and acquire consent before manuscript submission.
    • (6) References
      • 1) Cite only references which are quoted in the text. Limit the number of references 30.
      • 2) When quoting a reference in the text, refrain from stating the author’s last name, and identify references with Arabic numerals in parentheses such as (1), (2-4), and (5,7,9). If there are two authors, all authors' last names are included. If there are three or more authors, "et al." is attached after the first author's last name.
        Ex) Nogueras and Williams(3) is ~; Goldberg et al.(4) is ~
        If the last name of author is not indicated, citation of references should be made in parentheses after the comma or period.
      • 3) The references should be listed in order of citation in the text.
      • 4) List all authors when there are 6 or fewer; when there are 7 or more, list the first 6, followed by “et al.”
      • 5) Journal names should be abbreviated according to the format listed in the Index Medicus. If the journal is not listed in the Index Medicus, refer to the list of title word abbreviations by the ISSN network (http://www.issn.org/2-22660-LTWA.php).
      • 6) For more on references, refer to the NLM Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine).
    • Journals Kim YW, Han HS, Kim JP. The expression of bFGF m-RNA in gastric cancer tissues. J Korean Surg Soc 2000;59:746-50.
      Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele G Jr. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40:388-92.
      Cohnheim J. Congenitales quergestreigtes muskelsarkom der nieren. Virchows Arch 1875;65:64. Cited from Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hemotol 2004;51:1-28.
    • Book Gordon PH, Nivatvongs S. Principles and Practice of Surgery for the Colon, Rectum and Anus. 2nd ed. St Louis: Quality Medical Publishers; 1992.
    • Chapter in a book Dozois RR. Disorders of the anal canal. In: Sabiston DC, Lyerly HK, editors. Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 15th ed. Philadelphia: W.B. Saunders; 1997. p.1032-44.
    • Others Follow International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. (JAMA 1997; 277:927-34)
    • (7) Tables Tables should be submitted separately from the text, and each table should be created in MS Word on separate pages, using double space throughout. They should be simple, self-explanatory, and not redundant with the text or the figures. Limit 5 tables per manuscript. The title of the tables should be written in phrases, and capitalized the first letter of the first word. The title should be placed above the table, and abbreviations and footnotes are placed under the table. Number the tables in order of appearance in the text (e.g., Table 1, Table 2). All abbreviations used in the table must be spelled-out in full under the table in the following order: abbreviation, equals, full word (e.g., NS = not significant). For footnotes, the following symbols should be used, in this sequence: *, †, ‡, §, ∥, ¶, **, ††, ‡‡, etc. Citation of table should be made in parentheses before the comma or period.
    • (8) Figure Legends Legends should be submitted separately from the text, and each legend should be typed on separate pages. They should be written in full sentences to describe the content of the figure, and only the first letter of the legend should be capitalized. For lengthy legends continuing beyond one line, the left margin of the following lines should start at the same point as the first line. Any symbols, marks or abbreviations made in the figure must be explained in the legend. Figures containing histologic slides should be accompanied by legends explaining tissue origin, stain method, and microscopic amplification (e.g., H&E stain, ×100).
    • (9) Figures Figures should be uploaded online as separate files and numbered in order of appearance in the text (e.g., Fig. 1). When a single numbered figure contains 2 or more figures, the figure should be numbered with an alphabet letter following the number (e.g., Fig. 1A, Fig. 1B). Indicate focus points in the figures with markers such as arrows and arrowheads, etc. Image files must be of resolutions higher than 300 dpi, and less than 2 MB, in JPEG, GIF, TIFF, or Microsoft PowerPoint format. A single numbered figure containing more 2 or more figures such as Fig. 1A and Fig. 1B should be uploaded as a single file. Original drawings/photographs should be used for line drawing figures, and drawings/photographs from other sources should have approval from the original author.
  • 3. Other Form of Manuscripts
    • (1) Review article The invited review is a focused review of a specific topic written by an expert in the field nominated by the Editorial Board. The abstract should contain no more than 250 words and 5 Keywords. The text is structured in the order of Introduction, Main text, and Conclusion, Acknowledgments (when applicable), and the number of references should be limited to 60. Maximum page count (excepting tables and figures) is limited to 30 pages.
    • (2) Case report General guidelines and order of manuscript preparation are the same as for the original article. Case reports are considered for publication only if they report rare conditions, atypical clinical and laboratory findings, and novel diagnostic or therapeutic approaches.
      The Editorial Board will determine whether the case report fulfills the above criteria for acceptance of publication. The manuscript is structured in the order of Abstract, Introduction, Case report, Discussion, Acknowledgments (when applicable), References, Tables, and Figures. The abstract should be nonstructured and limited to 150 words, with no more than 3 Key Words attached. The introduction should briefly state the background and significance of the case. The actual case report should describe the clinical presentation and the diagnostic and therapeutic measures taken. The discussion should focus on the uniqueness of the case and should not contain extensive review of the disease or disorder. The combined number of tables and figures is limited to 5, and the number of references is limited to 10.
    • (3) Letter to the Editor A letter to the editor may be in response to issues from previously published articles, or short, free-standing opinion. If there are opinions from readers, those can be published with the decision of the editors. Describe briefly (A4 sized paper, 2-3 pages) and a maximum five references are allowed. Either tables or figures are allowed.
    • (4) Debate The invited author can subscribe discussion which is divided into the pros and cons in the field nominated by the Editorial Board.
    • (5) Special contributions Special contributions include those manuscripts for which content and style do not fall under the category of Original articles or Review articles; these may include guidelines, summaries of consensus meetings, and other scholarly communications which are invited by the Editorial Board.
    • (6) Image on ultrasonography In case of reporting new findings or techniques, describe it briefly (A4 sized paper, 4 pages) in essay form with image.
  • 4. Others For issues not addressed in these instructions, the author is referred to the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (http://www.icmje.org).

November 2020, 7 (2)